Benjamin Dewees

Benjamin Dewees is a seasoned professional in regulatory affairs and biotechnology, currently serving as Vice President of Global Regulatory Affairs at Kyverna Therapeutics since January 2023. Dewees has extensive experience, including the role of CEO at Aperiam Consulting, and previously held key positions such as Executive Director of Regulatory Affairs at Tenaya Therapeutics and Senior Director of Regulatory Affairs at Sangamo Therapeutics, Inc. Early career highlights include Vice President of Regulatory Affairs and Manufacturing at Acer Therapeutics Inc. and Associate Director of Regulatory Affairs at BioMarin Pharmaceutical Inc. Dewees holds a Professional Certificate in Biotechnology Manufacturing from the University of California San Diego Extension and a B.A. in Marine Biology from the University of California, Santa Cruz.